Covered recipient · General Payments record
SAMANTHA KAYE O'DELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$1,133.81
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.06 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exeltis, USA Inc. | $65.85 | 4 |
| Astellas Pharma US Inc | $60.90 | 3 |
| SHIELD THERAPEUTICS INC | $44.58 | 1 |
| Organon LLC | $28.62 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $27.39 | 1 |
| Sumitomo Pharma America, Inc. | $22.26 | 1 |
| Exact Sciences Corporation | $19.56 | 1 |
| Gynesonics, Inc. | $15.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $19.32 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139488002 | CMS |
| Astellas Pharma US Inc | $24.77 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139522978 | CMS |
| Astellas Pharma US Inc | $16.81 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139541084 | CMS |
| Boston Scientific Corporation | $27.39 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092556576 | CMS |
| Exact Sciences Corporation | $19.56 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114814262 | CMS |
| Exeltis, USA Inc. | $14.16 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150017455 | CMS |
| Exeltis, USA Inc. | $13.53 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150017457 | CMS |
| Exeltis, USA Inc. | $20.54 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150017459 | CMS |
| Exeltis, USA Inc. | $17.62 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150017461 | CMS |
| Gynesonics, Inc. | $15.90 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128625101 | CMS |
| Organon Llc | $6.75 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274831 | CMS |
| Organon Llc | $4.81 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274827 | CMS |
| Organon Llc | $12.19 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274835 | CMS |
| Organon Llc | $4.87 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136274839 | CMS |
| SHIELD THERAPEUTICS INC | $44.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150151176 | CMS |
| Sumitomo Pharma America, Inc. | $22.26 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148985206 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.